top of page
Search

New Patent Approval!

  • Writer: Biomedical Bonding
    Biomedical Bonding
  • Feb 21, 2021
  • 1 min read

Updated: Sep 30, 2021

BMB has secured a strong position in novel resin-based implants via granted patents in Europe and pending approval of patents in other key regions.


​The Patents protect the company's core technology, Bonevolent® in several aspects and it is used to innovate implant applications.


​It has been a key priority to reach these milestones to secure the foundation of the company’s goal of being a leader in this new field of implant solutions and lay ground for future expansion.






 
 
 

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page